InvestDashboard.com



Corbus Pharmaceuticals Holdings, Inc. (CRBP)



$2.1
52 Week Low
$7.2
2017-04-28 14:47:14 MDT
$10.78
52 Week High

Basic Info

Healthcare
Sector
Biotechnology
Industry
Nasdaq
Stock Exchange
United States
Country

Market Cap: $320,920,000Small Cap (Between $200M and $2B)
Analyst Recommendation:2Analysts say: Buy. (1=Strong Buy, 5=Strong Sell)
Beta: N/A Unknown Beta. A beta of 1 means that stock will go up or down at the same rate as the S&P 500 index.

Fundamentals

ForwardPE: Unknown
5 Yr Est Growth: Unknown
Yield: 0.00%
PEG-Y Ratio: N/A
Unknown PEG-Y ratio

Technicals

% Above 50 DayMA: -13.98%
% Above 200 DayMA: -8.16%
CRBP Performance 52 Weeks: 188.89%
S&P 500 Performance 52 Weeks: 12.50%
Downtrend is still intact: CRBP is below both 50 and 200 day Moving Averages. There is hope because 50 Day MA is still above 200 Day MA. Stock is closer to 52 Week High than 52 Week Low.
CRBP outperforming S&P 500 by 176.39% the last 52 Weeks.

Profile


More Valuation

Price To Book: 32.5
Not so great value. Low Price to Book means better value. A P/B value of 5 or less is great. But consider other metrics and maybe the growth and yield makes it worth it.
EV to EBITDA: -15.17
Unknown EV to EBITDA ratio

More Info

Field Value Average Comments
% Held By Insiders24.31% 17.28%Held by greater than average Insiders. Insiders can sway stock price. Watch insider buying and selling.
% Held By Institutions8.40% 62.07%Institutional percentage lower than average. Institutions may not have conviction in stock. Or is this a chance for institutions to invest more and boost price?
Short % Of Float16.58% 07.02% Shorted by greater than average percent. Investors and traders do not believe in stock. But watch out for short squeezes pushing stock upwards.
Debt to Equity0.03 1.08 More Conservative Financing. Each industry has different Debt/Equity standard. Higher than 1 means company is taking on more leverage.
Profit Margin %N/A-00.18%Unknown.
Operating Margin %-1.00%-05.28% Operating Margin greater than average percent. Good.
Return on Equity %-223.40%-08.79% Return on Equity less than average percent. Stock can do better than this?
Return on Assets %-81.20%-01.29% Return on Assets less than average percent. Stock can do better than this?
Revenue Per Employee $76,400.00 $883,096.70 Less than average Revenue Per Employee. This stock (or industry) might not be as efficient as others? Each industry might have a different standard.
Price to Cash 23.23 5.52 Higher than average Price to Cash. Meaning that the company has a lower percentage of cash as a percent of price. Cash can be good to cushion company during hard times, and as a potential source for buyouts or investments. However, some activists want the cash to be used by a company to buy its own stock, or to increase their dividend, or to invest the money.
CPEGY Ratio N/A 2.26Unknown.

Quick Thoughts

PROS:
  1. Analysts like this stock: 2 (1=Strong Buy, 5=Strong Sell)

  2. Stock outperforming S&P 500 over last 52 weeks: 176.39%

  3. Debt To Equity is lower than 1: 0.03

CONS:
  1. Stock is Below Short Term 50DMA: -13.98%

  2. Stock is Below Long Term 200DMA: -8.16%

  3. Price to Cash Ratio (23.23) is greater than average. Company has less cash as a percent of price than the average.

  4. Price to Book is over 10: 32.5

  5. Shorted more than average: 16.58%

  6. Operating Margin is negative: -1.00%

  7. Return on Equity is negative: -223.40%

  8. Return on Assets is negative: -81.20%


Headlines


Stock Chart


InvestDashboard.com CRBP: Corbus Pharmaceuticals Holdings, Inc.

This page updated Thu Feb 1 22:00:01 MST 2018.